Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Cystic Neoplasm 1 Malignant Liver Neoplasm 1 Liver Diseases 1 Carcinoma, Hepatocellular 1 Bone Cancer Metastatic 1

Interventions

atezolizumab 2 Control Groups 2 Blood Specimen Collection 2 Bevacizumab 2 repotrectinib 1 pembrolizumab 1 durvalumab 1 User-Centered Design 1 Standard of Care 1 Patient Navigation 1 Neuropsychological Tests 1 Neoadjuvant Therapy 1 Liver Transplantation 1 Injections 1 Immunotherapy 1 Electroporation 1 Catheter Ablation 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × Catheter Ablation × 1 year × Clear all

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡